Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guangjuan Zheng"'
Autor:
Lipeng Tang, Tong Li, Bowen Zhang, Zihao Zhang, Xiaoyi Sun, Ying Zhu, Bing Feng, Zuqing Su, Laijun Yang, Hongxia Li, Huazhen Liu, Yuchao Chen, Zhenhua Dai, Xirun Zheng, Mingxian Li, Chutian Li, Jie Zhao, Xinmin Qiu, Shuyan Ye, Han Liu, Guangjuan Zheng, Ben Li, Chuanjian Lu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Psoriasis is a chronic and inflammatory skin disorder characterized by inflammation and epidermal hyperplasia. Punicalagin (PUN) is a main active ingredient of pomegranate (Punica granatum L.) peel with multiple biological activities, such as antibac
Externí odkaz:
https://doaj.org/article/c361df0e584c47db8ed23c31edc9196c
Autor:
Zuqing Su, Kexue Zeng, Bing Feng, Lipeng Tang, Chaoyue Sun, Xieqi Wang, Caiyun Li, Guangjuan Zheng, Ying Zhu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Metabolic syndrome is characterized by central obesity, hyperglycemia and hyperlipidemia. Insulin resistance is the leading risk factor for metabolic syndrome. Kun-Dan decoction (KD), a traditional Chinese medicine, has been applied to tr
Externí odkaz:
https://doaj.org/article/1d4d49880e8045668c36a536c268c691
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Metabolic syndrome, characterized by central obesity, hypertension, and hyperlipidemia, increases the morbidity and mortality of cardiovascular disease, type 2 diabetes, nonalcoholic fatty liver disease, and other metabolic diseases. It is well known
Externí odkaz:
https://doaj.org/article/992715bf4371405093c4a9655ed4a703
Autor:
Ying Zhu, Zu-Qing Su, Chao-Yue Sun, Caiyun Li, Xieqi Wang, Lipeng Tang, Bing Feng, Kexue Zeng, Guangjuan Zheng
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background:Metabolic syndrome is characterized by central obesity, hyperglycemia and hyperlipidemia. Insulin resistance is the leading risk factor for metabolic syndrome. Kun-Dan decoction (KD), a traditional Chinese medicine, has been applied to tre
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss, Pp 518-527 (2019)
Cisplatin-based chemotherapeutic regimens are the most frequently used adjuvant treatments for many types of cancer. However, the development of chemoresistance to cisplatin results in treatment failure. Despite the significant developments in unders
Autor:
Ying Zhu, Liu-Mei Wu, Chao-Yue Sun, Juan Nie, Guangjuan Zheng, Zuo-Liang Zheng, Jie Zhao, Zu-Qing Su, Bing Feng
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 112, Iss, Pp-(2019)
Cisplatin remains the standard first-line chemotherapeutic agent in the treatment of many types of cancers, but its clinical application is hindered by its severe nephrotoxicity. Previous studies reported that scutellarin enhanced the anti-cancer act
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 117, Iss, Pp-(2019)
Cisplatin is one of the most frequently used chemotherapeutic agents for treatment of a wide range of cancer types. Nevertheless, the intrinsic or acquired resistance to cisplatin remains a major obstacle for cancer therapy. There are a number of fac